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Summary. Although traditionally little attention has
been paid to the interplay between neurotrophins and the
cell cycle, a number of recent findings suggest an
important role for these growth factors in the regulation
of this aspect of the cellular physiology. 
In this article, we review the evidence from a
number of studies that neurotrophins can influence cell
cycle progression or mitotic cycle arrest both in the
nervous system as well as in other cell types. The
contrary response of different cells to neurotrophins in
terms of cell cycle regulation derives in part from the
fact that these factors use two different receptor types to
transmit their signals: members of the Trk family and the
p75 neurotrophin receptor (p75NTR). With this in mind,
we outline the current state of our knowledge regarding
the molecular basis underlying the control of cell cycle
progression by neurotrophins. We focus our interest on
the receptors that transduce these signals and, in
particular, the striking finding that p75NTR interacts with
proteins that can promote mitotic cycle arrest. Finally,
we discuss the mechanisms of cell death mediated by
p75NTR in the context of cell cycle regulation.
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Introduction
A prominent feature of the mature vertebrate
nervous system is that the main cellular components, the
neurons, are postmitotic. This implies that precursors
that proliferate vigorously during the initial stages of
development, must withdraw from the cell cycle in order
to differentiate. Both proliferation and cell cycle arrest
are tightly regulated by a number of intrinsic and
extrinsic signals that include proneural and neurogenic
gene products as well as other extracellular factors.
Although traditionally, little attention has been paid to
the interplay between neurotrophins and cell cycle
regulation, recent advances suggest that these growth
factors fulfill critical roles in the control of the mitotic
cycle, both in the nervous system and also in other cell
types.
The neurotrophin family is made up of non-
covalently-associated, homodimeric proteins: namely,
nerve growth factor (NGF), brain-derived neurotrophic
factor (BDNF), neurotrophin3 (NT3), and
neurotrophin4/5 (NT4/5). For many years, these
molecules have been known to be key players during the
development of the nervous system. Thus, they are
involved in regulating survival and death as well as
controlling synaptic plasticity and the maintenance of
neural networks (for recent reviews, see Bibel and
Barde, 2000; Huang and Reichardt, 2001). However, the
molecular basis underlying these functions is still not
fully understood. Indeed, understanding the behavior of
neurotrophins is complicated by the fact that their
signals are mediated through two different types of
receptors: the members of the tropomyosin receptor
kinase (Trk) family, and the p75 neurotrophin receptor
(p75NTR).
The Trk family of receptor tyrosine kinases (RTKs)
is made up of three different neurotrophin receptors,
each with a different specificity: TrkA binds to NGF,
TrkB to BDNF and NT4/5, and TrkC binds to NT3
(reviewed by Bothwell, 1995). These receptors are
monomeric proteins with two immunoglobulin (Ig)
domains in the extracellular region, and a tyrosine kinase
domain located in the cytoplasmic tail (Fig. 1). The
binding of neurotrophins to the Ig domains triggers
dimerization of the receptor and activation of the kinase,
thus initiating signal transduction (see below).
Importantly, both the TrkB and TrkC genes undergo
alternative splicing and can produce different isoforms
with truncations or insertions in the tyrosine kinase
domain (Klein et al., 1990; Lamballe et al., 1993). These
alterations confer distinct biological properties to the
receptors.
p75NTR is a member of the tumor necrosis factor
receptor family and it is expressed by a variety of
neuronal and non-neuronal cell types. Structurally,
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et al., 1994; Bentley and Lee, 2000), and the most
studied effect, the induction of cell death (for a recent
review, see Miller and Kaplan, 2001). 
In the following pages, we will discuss recent
findings that highlight the importance of neurotrophins
and in particular p75NTR-mediated signals in the
regulation of the mitotic cycle both in the nervous
system as well as in other cell types. We will also
discuss the mechanisms controlling neurotrophin and
p75NTR-mediated cell death in the context of cell cycle
regulation.
Neurotrophins and cell cycle regulation
Neurotrophin-dependent regulation of the mitotic cycle in
non-neural cells
During recent years, many reports have been
published describing the mitogenic effects of
neurotrophins in tumor cell lines and primary cultures of
non-neural origin. While in some cases there is no
indication as to which neurotrophin receptor might be
mediating this effect (e.g. NGF-dependent changes in
DNA synthesis in rat splenic mononuclear cells; Thorpe
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Fig. 1.  Structure of Trk receptors and their signal transduction
pathways regulating cell cycle progression. Trk receptors are
transmembrane proteins containing three characteristic tandem leucine-
rich motifs (dark grey ovals) flanked by two cysteine clusters (light grey
rectangles) and two immunoglobulin domains (black segments) in the
extracellular region. They have one single transmembrane motif (dark
grey segment) and one tyrosine kinase domain (light grey segment)
located in the cytoplasmic tail. Upon binding to their neurotrophin
ligands, Trk receptors dimerize and activate their tyrosine kinase
domain, thus becoming autophosphorylated on specific tyrosine
residues. Phosphorylated Y490 (Y; in the human sequence) plays an
important role in the initiation of signaling cascades that end up
regulating the cell cycle. Depending on the adaptor proteins that bind to
Y490, Trk receptors may transduce cell cycle promotion or cell cycle
arrest (see text). Thick arrow: prolonged activity, dashed arrow:
transient activity.
Fig. 2.  Structure of p75NTR and signal pathways initiated upon its
activation by neurotrophins which may end up in cell cycle regulation.
p75NTR is a transmembrane receptor characterized by an extracellular
domain containing four cysteine repeats (ovals), a single
transmembrane domain (small rectangle), and an intracellular tail
containing a highly conserved juxtamembrane motif (black line), and a
class II death domain (large rectangle). Binding of neurotrophins to
p75NTR stimulates a number of pathways depending on the cellular
context. A number of proteins have been described that interact with the
intracellular domain of p75NTR and that are involved in the regulation of
the cell cycle (SC-1, NRAGE, NRIF1/2). RhoA can also interact with the
intracellular domain of p75NTR and might indirectly regulate the cell cycle
(dashed arrow). Additional pathways initiated by p75NTR, and indicated
with short arrows, may indirectly end up in cell cycle regulation (dashed
arrows). These pathways include the activation of ceramide (Cer), c-Jun
N-terminal kinase (JNK), Rac, NF-kB, and Ras (see text). 
p75NTR is a single transmembrane receptor with an
intracellular tail that contains a type II death domain
(Fig. 2). Initially, p75NTR was identified as a receptor for
NGF (Johnson et al., 1986; Radeke et al., 1987) but as
other members of the neurotrophin family were
described, it became clear that it was able to bind all the
neurotrophins (Rodríguez-Tébar et al., 1990, 1992). The
transcendence of the identification of p75NTR as a
universal neurotrophin receptor was devalued by the
lack of any obvious catalytic motif within its
cytoplasmic domain that could mediate its cellular
function. Indeed, when the members of the Trk family
were shown to specifically bind and transmit the trophic
signals initiated by the neurotrophins (reviewed by
Barbacid, 1994), p75NTR was considered as a secondary
player in studies of the neurotrophin family. It was not
until the mid-nineties that it became clear that p75NTR
itself can transmit signals and that it fulfilled specific
functions during both development as well as in
adulthood. Indeed, it has been associated with the
processes of axonal outgrowth (Yamashita et al., 1999;
Bentley and Lee, 2000), Schwann cell migration (Anton
and Perez-Polo, 1987), in the majority of cases,
neurotrophin-dependent mitogenic activity is related to
the expression of Trk receptors. This fact is not
surprising since the first member of this family, TrkA,
was originally isolated as an oncogene from a colon
carcinoma. The transformation of TrkA involves the
fusion of the extracellular portion of the TrkA protein
with that of tropomyosin, leading to the constitutive
activation of the protein kinase (Martín-Zanca et al.,
1986). As we will discuss below, the molecular basis for
the mitogenic capacity of the Trk receptors probably
derives from their interactions with the many
intracellular signaling pathways that are regulated by
mitogens.
In the light of this, it is therefore not surprising that
one of the first biological responses attributed to the Trk
receptors was their mitogenic effects. In fibroblasts, cells
that do not normally express either p75NTR or Trk
receptors, exposure to neurotrophins elicits a growth
response if expression of a Trk receptor is induced
(Cordon-Cardo et al., 1991; Glass et al., 1991; Klein et
al., 1991; Lamballe et al., 1991; Soppet et al., 1991).
This demonstrates the potential of these molecules to
promote proliferative signals and subsequently, many
other examples of the mitogenic effects of Trk activation
have been reported.
The mitogenic effects of neurotrophins can also be
seen when NGF induces proliferation mediated by TrkA,
in human breast cancer cells, primary human myoblasts,
and thecal cells from antral ovarian follicles (Dissen et
al., 2000; Rende et al., 2000; Chiarenza et al., 2001;
Descamps et al., 2001). In addition, concentrations of
NGF that activate only high-affinity receptors have been
shown to promote proliferation in human B lymphocytes
and lymphoblastoid B-cell lines cultured in vitro (Otten
et al., 1989; Kimata et al., 1991). NGF is also capable of
triggering proliferation in corneal cells (You et al.,
2000). In vivo, overexpression of truncated forms of
TrkC lacking its tyrosine kinase domain prevents
proliferation of cardiac myocytes, suggesting that TrkC
might promote mitogenic effects during early heart
development (Lin et al., 2000). In addition, BDNF, NT3
and NT4/5 all promote proliferation in murine skin
(Botchkarev et al., 1999). However, whether or not Trk
receptors are mediators of this latter effect remains
uncertain.
In contrast, the presence of p75NTR seems to trigger
withdrawal from the cell cycle in some tumor cell lines
that show a mitogenic response to neurotrophins. This
indicates that, as previously described for pro-apoptotic
signalling (Yoon et al., 1998; Davey and Davies, 1998)
and in neurite outgrowth (Kohn et al., 1999), p75NTR
produces an opposite effect to that of the Trk receptors in
terms of cell cycle progression. This has been
demonstrated in some pancreatic cancer cell lines whose
response to NGF, either mitogenic or anti-mitogenic,
depends on the balance of TrkA and p75NTR expression
(Zhu et al., 2001). In these cells, NGF-induced
mitogenesis is associated with TrkA phosphorylation,
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whereas those cell lines with low TrkA levels and high
or moderate p75NTR expression respond to NGF by
reducing their growth. A similar effect was also
observed in a human prostate epithelial tumor cell line,
which expresses TrkA and responds to NGF by
promoting mitogenesis. This NGF-dependent growth
response can be prevented in this cell line by the stable
expression of p75NTR (Pflug and Djakiew, 1998).
Neurotrophin-dependent regulation of the mitotic cycle in
cells of neural origin
As well as in non-neural cells, there is increasing
evidence that neurotrophins can provide either positive
or negative mitogenic signals in neural cells. In vitro,
NGF induces mitogenesis in chromaffin cells from
young rats (Lillien and Claude, 1985), cochleovestibular
ganglia isolated from chick embryos (Represa and
Bernd, 1989), precursor cells from the rat striatum
(Cattaneo and McKay, 1990), and cerebellar neuroblasts
(Confort et al., 1991). Additionally, NT3 is mitogenic in
cultures of quail neural crest cells (Kalcheim et al.,
1992), and addition of exogenous NT4/5 to purified
cultures of oligodendrocyte/type-2 astrocyte progenitors
maintained in an undifferentiated state results in an
increase in proliferation (Scarisbrick et al., 2000). In
vivo, further examples of mitogenic signals initiated by
neurotrophins can be found, although in these cases
indirect mechanisms cannot be ruled out. Hence, both
NGF and NT3 have been shown to stimulate cell
proliferation in premigratory precursors of cerebellar
granule neurons (Muller et al., 1994; Katoh-Semba et al.,
2000). Moreover, the presence of fibroblasts producing
BDNF or NT3 augmented the number of BrdU-positive
oligodendrocytes following spinal cord injury (McTigue
et al., 1998).
Anti-mitogenic signals that induce cell cycle
withdrawal can also be observed upon treatment with
neurotrophins in cells of neural origin. Perhaps the best
documented example of cell cycle withdrawal induced
by a neurotrophin is the classical differentiation of PC12
cells in response to NGF (Greene and Tischler, 1976).
When these cells are exposed to NGF, cell division is
inhibited, resulting in the cells becoming large, rounded,
and developing abundant neurite networks. Additionally,
in cultures of rat cortical precursor cells, exogenous NT3
appears to suppress proliferation and promote neuronal
differentiation (Ghosh and Greenberg, 1995). In the
chick retina, NT3 is involved in the withdrawal from the
cell cycle of precursors that differentiate as G4-positive
neurons (de la Rosa et al., 1994). Furthermore, inhibition
of NT3 activity in the embryonic chick retina in vivo
results in a reduction in neuronal differentiation and the
maintenance of mitotic precursors (Bovolenta et al.,
1996). In vivo, application of NT3 early in development
leads to a marked decrease in the number of proliferating
neuroblasts in sensory ganglia (Ockel et al., 1996).
Efforts have been made to identify which
neurotrophin receptors are responsible for either the
positive or negative effects on cell cycle progression.
This ongoing analysis seems to indicate that cell cycle
regulation by both Trk and p75NTR in neural cells is
much more flexible than in those cells of non-neural
origin. Thus, Trk activity can either prevent or promote
mitogenesis, and the same can be seen for p75NTR.
Several examples can be found of proliferation
induced by neurotrophins and mediated by Trk
receptors. Exposure of cultured human Müller glial cells
to NGF in serum-free conditions provokes a
concentration-dependent increase in cell number and
BrdU incorporation. This effect is inhibited by K252α, a
specific antagonist of the family of neurotrophin-linked
RTKs, suggesting that TrkA is involved (Ikeda and Puro,
1994). Proliferation is also potentiated by NGF in
glioblastoma multiforme cell lines, where TrkA and
p75NTR are both expressed, and this effect is also
blocked by K252α (Singer et al., 1999). However, the
high dose of NGF that was used in this study might
undermine the relevance of these data. All neurotrophins
are capable of inducing proliferation in Y-79
neuroblastoma cells through the activation of Trk
receptors (Wagner et al., 2000), and oligodendrocyte
precursors can respond to NT3 through TrkC by
increasing the expression of proteins involved in S-phase
entry (Kumar et al., 1998). Furthermore, the mitogenic
effect of platelet-derived growth factor is consistently
potentiated by NT3 in optic nerve oligodendrocyte
precursors, but not in spinal cord oligodendrocyte
precursors that do not express TrkC (Barres et al., 1994;
Robinson and Miller, 1996). These responses to NT3
were sensitive to the presence of K252α (Kumar et al.,
1998).
Examples where different Trk receptors expressed
by a particular cell type can trigger distinct mitogenic
effects can also be found in the literature. Thus, TrkB
induces the growth of SH-SY5Y neuroblastoma cells
when activated by BDNF, while NGF inhibits growth
when these same cells are transfected with its receptor
TrkA (Eggert et al., 2000). Similarly, Trk receptors seem
to initiate antimitotic responses in other cells of neural
origin. Thus, TrkA is involved in NGF-induced growth
arrest of PC12 cells since the NGF∆9/13 mutant protein
which binds poorly to TrkA and therefore, does not
stimulate kinase activity, does not cause the cell cycle
arrest that is seen with native NGF (Hughes et al., 2001).
In addition, non-catalytic TrkC isoforms generated by
alternative splicing have been implicated in cell cycle
withdrawal and differentiation. This is consistent with
the expression pattern reported for the mouse TrkC NC2
isoform in the developing nervous system, which is
associated with regions undergoing abundant neuronal
differentiation. TrkC NC2 expression coincides with the
exit of neuronal progenitors from the cell cycle and it is
maintained in differentiated cerebellar neurons in
conjunction with p75NTR expression (Menn et al., 1998,
2000). In addition, a truncated form of TrkC is also
involved in neural crest differentiation in collaboration
with p75NTR (Hapner et al., 1998). These studies suggest
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that p75NTR, in collaboration with truncated TrkC, might
be involved in providing the signals for cell cycle
withdrawal that are associated with neuronal
differentiation. Interestingly, infection of early chick
retinas with retroviral vectors that over-express a
truncated isoform of TrkC produces clones with a
significant reduction in their size and mainly composed
of neural phenotypes that correspond to those born at the
early stages of retina development (Prada et al., 1991;
Das et al., 2000). This suggests that the presence of
exogenous truncated TrkC triggers cell cycle withdrawal
and differentiation in this tissue. Similar truncated
isoforms of TrkC are observed in the vertebrate retina
(Valenzuela et al., 1993), suggesting that endogenously-
expressed truncated TrkC might be involved in cell cycle
arrest and differentiation, maybe through its interaction
with NT3, a neurotrophin which promotes neurogenesis
in the chick retina both in vivo and in vitro (de la Rosa et
al., 1994; Bovolenta et al., 1997). In addition, p75NTR
might cooperate in provoking the cell cycle arrest and
differentiation promoted by NT3 since this receptor is
expressed by the first phenotypes produced in the chick
retina (von Bartheld et al., 1991). The possibility that
over-expression of truncated TrkC competes with
endogenous full length TrkC, inhibiting a putative
proliferative effect of this receptor cannot be ruled out,
although it seems unlikely (Das et al., 2000). At
concentrations at which NT3 binds to its high affinity
receptor, proliferation is not induced in cultured retinal
precursors (de la Rosa et al., 1994).
As is the case for non-neural cell types, p75NTR can
sometimes also transmit proliferation signals in neural
cells. Thus, in vivo, NGF augments proliferation in
primary sympathetic ganglia of chick embryos,
presumably by acting through p75NTR since TrkA has
not been detected in the avian sympathetic ganglia until
later on in development (Goldstein et al., 1997).
Although the presence of NGF also reduced the low
level of cell death that is observed in sympathetic
ganglia in vivo, the effect of NGF on proliferation was
apparent owing to the twofold increase in the proportion
of cells in S-phase.
One explanation of the pro-mitogenic vs. anti-
mitogenic effects of p75NTR and/or Trk receptors might
lie in the cell cycle-dependent expression of these
receptors. Thus, p75NTR protein has been reported to be
increased on the surface of neural crest-derived cells
during mitosis in vivo (Young, 2000). In contrast, PC12
cells present higher superficial levels of p75NTR in their
surface at late G1, S and G2, whereas TrkA is more
highly expressed in M-phase and early G1 (Urdiales et
al., 1998). In PC12 cells, NGF triggers differentiation
during the G1/G0 phase, confirming that TrkA plays a
crucial role in cell cycle withdrawal (see above),
whereas at other phases of the cell cycle when p75NTR is
predominantly expressed at the cell surface, NGF
provokes survival (Urdiales et al., 1998). It is thus
conceivable that, in a particular cell type, the decision to
progress or withdraw from the mitotic cycle could be
control of cell cycle via Trk receptors relates to the
integrity of their tyrosine kinase homology region. Thus,
splice variants of TrkC with amino acid insertions in the
kinase domain do not mediate the mitogenic activity of
NT3 in fibroblasts (Valenzuela et al., 1993; Guiton et al.,
1995). The presence of these insertions is manifested by
the lack of high affinity binding of Shc and
phospholipase C-γ to the TrkC variants, and this
interferes with the biological response to NT3 in
fibroblasts (Guiton et al., 1995). Additionally, the
signaling triggered by Trk receptors in terms of cell
cycle regulation is also dependent on functional cross-
talk between Trk and p75NTR (see below).
p75NTR-dependent signals regulating the cell cycle
We have seen that p75NTR can regulate the cell cycle
in both cells of neural and non-neural origin. Possible
mechanisms that might underlie this behavior have been
highlighted recently. Proteins that interact with the
intracellular domain of p75NTR and second messengers
that are activated by this receptor and that are capable of
regulating the cell cycle have been described.
Two such proteins are the neurotrophin receptor
interacting factor (NRIF)1 and NRIF2, zinc finger-
containing proteins that interact with the intracellular
domain of p75NTR and that can influence the mitotic
cycle (Casademunt et al., 1999; Benzel et al., 2001). In
the C57/BL6 mouse strain, the functional null mutant of
the nrif1 gene results in significantly smaller embryos
which do not survive beyond E12, a phenotype that is
consistent with cell cycle arrest (Benzel et al., 2001).
Strikingly, when either NRIF1 or NRIF2 are transiently
expressed in human embryonic kidney 293T cells, the
rate of proliferation is also markedly decreased (Benzel
et al., 2001) suggesting that quantitative changes in the
levels of both NRIF molecules can interfere with the
progression of the mitotic cycle.
Another zinc finger protein that interacts with the
intracellular tail of p75NTR is SC-1. This protein contains
six zinc finger motifs and one positive regulatory (PR)
domain, previously identified as a common domain in
several transcription factors including the tumor
suppressor, retinoblastoma-interacting zinc finger (RIZ)
protein. SC-1 interacts with p75NTR and in response to
the specific activation of this receptor by NGF, it
translocates to the nucleus in COS cells, an effect that is
blocked by the expression of TrkA (Chittka and Chao,
1999). The presence of SC-1 in the nucleus correlates
with the loss of BrdU incorporation, indicating that this
protein is a clear candidate for mediating the anti-
proliferative effects triggered by the activation of
p75NTR. Disrupting the translocation of SC-1 to the
nucleus may represent a mechanism to prevent growth
arrest in cells co-expressing both TrkA and p75NTR and
as such provide a means by which TrkA can promote
mitogenesis (see above).
A further p75NTR interacting protein that has
recently been implicated in cell cycle regulation is the
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mediated by the neurotrophin receptor, Trk or p75NTR,
which is being expressed at the time when the decision
takes place, normally at G1/G0.
Molecular basis for cell cycle regulation dependent
on neurotrophins
Trk-dependent signals regulating the cell cycle 
Neurotrophin binding to Trk receptors results in
dimerization and activation of their tyrosine kinase
domain, resulting in autophosphorylation of conserved
tyrosines in the cytoplasmic tail. Seven of these
phospho-tyrosines create docking sites for adaptor
proteins that couple these receptors to intracellular
signaling cascades, including the extracellular signal-
regulated kinase (ERK) pathway, the phosphatidyl-
inositol-3-OH kinase/Akt kinase pathway, and the
phopholipase C-γ pathway (reviewed by Kaplan and
Miller, 2000; Patapoutian and Reichardt, 2001). These
signaling cascades are responsible for the multiplicity of
cellular events controlled by the Trk receptors.
In a similar manner to other RTKs, Trk receptors can
provide signals to stimulate proliferation, or cell cycle
withdrawal and differentiation, depending on the cellular
context in which the transduction pathway is activated
(Marshall, 1995; Grewal et al., 1999; Meakin et al.,
1999). The molecular basis that determines whether
exposure to neurotrophins results in proliferation or cell
cycle arrest seems to depend on whether there is a
transient or prolonged activation of the ERK pathway
(Marshall, 1995; Patapoutian and Reichardt, 2001). In
each case, the recruitment of different adaptor proteins to
the phosphotyrosine Y490 in the human sequence
initiates defined signal transduction cascades (Fig. 1).
Signals triggering cell cycle progression upon Trk
activation seem to depend on Shc recruitment to Y490.
This interaction is subsequently translated into the
recruitment of the Grb-2 and Ras exchange factor Son of
sevenless (SOS), which in turn promotes transient
activation of Ras (Borrello et al., 1994; York et al.,
1998), thereby triggering the c-Raf/ERK pathway and
proliferation (York et al., 1998). Alternatively, the
prolonged activation of ERK can be initiated by
recruitment of the adaptor protein fibroblast growth
factor receptor substrate (FRS)-2 to Y490 (Meakin et al.,
1999). FRS-2 is then phosphorylated, thereby creating
docking sites for adaptor proteins such as Crk and Src-
homology protein kinase phosphatase (SH-PTP)-2
(Meakin et al., 1999). Once bound to FRS-2, Crk binds
and activates the guanine nucleotide exchange factor
C3G (Nosaka et al., 1999), which in turn activates the
small G protein Rap-1. Rap-1 activates B-raf and ERK
signaling in a prolonged manner (York et al., 1998;
2000), thus promoting cell cycle withdrawal and
differentiation. Prolonged activation of ERK seems also
to be facilitated by other proteins like SH-PTP-2 (Wright
et al., 1997).
A further degree of complexity to be added to the
neurotrophin-receptor-interacting MAGE homolog,
NRAGE (Salehi et al., 2000). This protein is a member
of the melanoma antigen (MAGE) family of proteins,
initially characterized as precursors of a number of cell-
surface antigens expressed by tumor cells. NRAGE
induces cell cycle arrest when over-expressed in human
embryonic kidney 293 cells. Within the developing
CNS, NRAGE colocalizes with p75NTR in the mantle
zone, a region where neurons are born, suggesting that
NRAGE might participate in the mechanisms that
control the arrest of growth that takes place during
neurogenesis. Interestingly, TrkA seems to compete with
NRAGE for the same binding site in p75NTR. Thus,
over-expression of NRAGE blocks the physical
association of p75NTR with TrkA (Salehi et al., 2000),
again emphasising the opposing interactions between
these two receptors.
The small GTPase RhoA interacts with, and is
activated by the cytoplasmatic domain of p75NTR, in the
absence of neurotrophin binding. Upon interacting with
neurotrophins, RhoA is inactivated, thus promoting
axonal outgrowth (Yamashita et al., 1999). Interestingly,
RhoA is known to be involved in controlling the
formation of the cytoskeletal ring during cytokinesis,
presumably by activation of citron kinase, Rho kinase
I/II, formin-homology proteins, and a regulatory subunit
of a myosin phosphatase (for a review, see Glotzer,
2001). In addition, RhoA is required for the expression
of cyclin D1 in mid-G1, through a mechanism involving
sustained ERK activity (Welsh et al., 2001), a finding
that suggests a new link between the cell cycle and
signals derived from Trk and p75NTR activation. The
inhibition of RhoA upon interaction of neurotrophins
with p75NTR, might therefore be part of the complex
molecular process involved in cell cycle arrest and the
morphological differentiation observed in different cells
upon activation of this receptor.
Some second messengers such as ceramide, which
are generated upon p75NTR activation might also
influence cell cycle progression (Dobrowsky et al.,
1994; Dobrowsky and Carter, 1998). Numerous studies
have demonstrated that ceramide is able to trigger
G1/G0 arrest by inducing hypophosphorylation of Rb
(Dbaibo et al., 1995; Venable et al., 1995). This may
result from cyclin-dependent kinase (CDK) 2 inhibition
by the ceramide-activated protein phosphatase (CAPP;
Dobrowsky et al., 1993; Galadari et al., 1998; Lee et al.,
2000), and the expression of the CDK inhibitor
p21cip1/waf1 (Alesse et al., 1998; Kim et al., 2000; Lee
et al., 2000). Another target of ceramide is the c-jun N-
terminal kinase (JNK), which has been shown to
participate in ligand-dependent apoptosis induced by
p75NTR (see Kaplan and Miller, 2000). Interestingly,
there is increasing evidence that stress kinases like JNK
are involved in either promoting or preventing cell-cycle
progression (for a recent review, see Pearce and
Humphrey, 2001), thus suggesting another potential link
between p75NTR signalling and the regulation of the cell
cycle.
Several studies have highlighted the association
between cell survival and the activation and nuclear
translocation of NF-κB as the result of NGF activating
p75NTR (Carter et al., 1996; Bhakar et al., 1999; Cosgaya
and Shooter, 2001). Members of the NF-kB family are
known to potentiate the proliferative response to
mitogenic factors, and the best explored link between
NF-kB activation and cell cycle progression involves
transcriptional activation of the cyclin D1 gene (for a
review see Joyce et al., 2001). Therefore, NF-κB might
participate in the positive modulation of the cell cycle
observed on activation of p75NTR. Thus, depending on
the prevalence of the NF-κB or ceramide/JNK pathways,
the response to p75NTR activation might involve either
proliferation or cell cycle arrest, respectively. This
situation is reminiscent of the cell death/survival signals
regulated by p75NTR, which have also been shown to
depend on the activation of either of these second
messengers (see Kaplan and Miller, 2000). 
Another small GTPase that has been shown to
mediate responses to p75NTR is the protooncogene Rac.
Rac is activated by the interaction of NGF with p75NTR
and, by activating JNK, promotes cell death in cortical
oligodendrocytes (Harrington et al., 2002). Interestingly,
Rac has been implicated in cell cycle regulation, mainly
as a result of integrin-mediated cell adhesion inducing
cyclin D1 or as a downstream effector of Ras (reviewed
by Ridley, 2001). Therefore, Rac might be another
potential candidate for the mitogenic effects promoted
by p75NTR.
Finally, some evidence exists that p75NTR and Trk
receptors can share signaling pathways that regulate the
cell cycle. Thus, the stimulation of p75NTR with NGF
has been shown to activate Ras and induce a fast and
transient phosphorylation of p44 MAPK and p42 MAPK
(ERK1 and ERK2, respectively) in P2 rat cerebellar
cultures and PCNA cells (Susen et al., 1999). In this
case, the NGF-mediated signals were independent of
TrkA which is not expressed in these cells. Thus, it can
be inferred from these findings that a signal transduction
pathway based on the transient activation of ERK,
known to result in a proliferative response when initiated
by Trk receptors (see above), could also represent an
alternative mechanism by which p75NTR promotes cell
cycle progression.
Cell cycle regulation and apoptosis mediated by
p75NTR
The recent findings demonstrating that p75NTR can
interact with molecules involved in cell cycle regulation
raises the intriguing possibility that in some cases the
known apoptotic effect of p75NTR may be secondary to
conflicting signals for cell division and growth arrest
(O’Connor et al., 2000). This possibility may be
particularly important in cases where postmitotic
neurones either lack antiproliferative signals or receive
proliferative inputs.
Cumulative evidence indicates that once a neuronal
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precursor has withdrawn from the mitotic cycle, re-entry
is not allowed and, that if the control of this process
breaks down, the cell dies (Liu and Greene, 2001).
Recent data also suggest that the mechanisms to prevent
re-entry into the cell cycle of newly-born neurons
depend, at least in part, on the continuous presence of
neurotrophins at critical stages. Thus, when the SH-
SY5Y neuroblastoma cell line is sequentially exposed to
retinoic acid and BDNF in serum-free medium, cells
withdraw from the cell cycle and generate a
homogeneous population of cells with a neuronal
morphology. Cell survival is therefore dependent on the
continuous presence of BDNF, and removal of this
neurotrophin induces cell death which appears to result
form the attempt to re-enter the cell cycle (Encinas et al.,
2000). A similar situation is observed in vivo when
dorsal root ganglion neurons, in the absence of NT3, fail
to detain the cell cycle, override the G1 restriction point,
and die in S phase after having upregulated several
proteins required for entry into the cell cycle (ElShamy
et al., 1998). Other studies have reached similar
conclusions. Thus, survival of sympathetic neurons in
culture is dependent on a permanent supply of NGF,
which mediates its effects through the activation of
TrkA, a receptor highly expressed by this neuronal
population. In the absence of NGF, these neurons die
concomitant with the upregulation of cyclin D1
(Freeman et al., 1994). Inhibitors of cyclin-dependent
kinases as well as dominant negative forms of CDK4/6
are able to prevent their death (Park et al., 1996, 1997),
suggesting that the apoptotic process is a consequence of
an attempt to re-enter the cell cycle. Sympathetic
neurons can be maintained alive in the absence of NGF
by treatment with KCl and, under these circumstances,
BDNF can trigger p75NTR-mediated apoptosis in these
neurons (Bamji et al., 1998). Whether or not this effect is
the result of sympathetic neurons attempting to re-enter
into the cell cycle, as occurs after NGF deprivation in
the absence of KCl, is unknown. Nevertheless, this
might well be the case, as the signals provoked by
BDNF treatment are similar to those observed after
NGF-deprivation. In both cases the activation of the
JNK-p53-Bax pathway has been shown to be necessary
for the induction of cell death (Aloyz et al., 1998).
An additional example of cell death regulated by
neurotrophins in the context of cell cycle regulation
comes from studies in the developing chick retina. In
this tissue, the presence of BDNF can prevent apoptosis
in newly-born neurons that die during early stages of
development as a consequence of the interaction of NGF
with p75NTR (Frade et al., 1996, 1997). The
antiapoptotic effect of BDNF is likely to be triggered by
TrkB as this receptor is expressed early in retinal
development (Frade et al., 1997). When retinal precursor
cells are cultured without BDNF in conditions that favor
differentiation, a percentage of these cells express the
neuronal marker G4 and die in the presence of NGF as a
consequence of p75NTR activation. This induction of
apoptosis is prevented by BDNF, and occurs after a rise
of cyclin B2 levels and in the presence of mitotic figures
amongst the G4-positive neurons (Frade, 2000).
Interestingly, BDNF prevents both the ectopic
expression of cyclin B2 and cell cycle re-entry in post-
mitotic, NGF-treated neurons expressing G4 (Frade,
2000), and the effect of BDNF can be mimicked by
drugs that prevent cell cycle progression.
A possible molecular link between the p75NTR-
dependent upregulation of cyclin B2 in retinal neurons
and cell death might reside in the activation of the tumor
suppressor gene p53, as described for sympathetic
neurons. Indeed, the inappropriate activation of cell
cycle regulatory molecules is known to induce the
expression of p19ARF, which subsequently activates p53
and leads to apoptosis via a pathway independent of
DNA damage (Sherr, 1998). Alternatively, p53 might be
directly activated by JNK, a second messenger involved
in p75NTR-induced cell death which has been clearly
linked to the activation of p53 in the sympathetic neuron
paradigm (Aloyz et al., 1998).
Another protein that seems to participate in the
induction of cell death in retinal neurons is NRIF1
(Casademunt et al., 1999; Benzel et al., 2001). The role
of NRIF1 in mediating apoptosis in the mouse
embryonic retina was highlighted by the significant
reduction in the levels of cell death in retinas from
mutant mice in which the NRIF1-binding site for p75NTR
is absent (Casademunt et al., 1999). This effect is
indistinguishable from that observed in the retina of
p75NTR-/- and ngf-/- mutants (Frade and Barde, 1999). 
Mice mutant for nrif1 in the C57/BL6 genetic
background are embryonically lethal due to a general
failure in the progression of the cell cycle at early stages
of development (Benzel et al., 2001). This fact suggests
an important role for NRIF1 in mitotic cycle
progression. Strikingly, nrif1 mutants are viable in the
Sv129 background, and no effects in terms of cell cycle
arrest are observed in these mice. This apparent
contradiction is explained by the upregulation of NRIF2
in the Sv129 background, which probably compensates
for most NRIF1 functions. Nevertheless, in these mice,
NRIF2 does not seem to be able to replace NRIF1 in its
ability to regulate cell death since the functional
depletion of NRIF1 results in a lower apoptosis in the
mouse retina. A role for NRIF1 in triggering p75NTR-
dependent apoptosis in the developing mouse retina
would be consistent with NRIF1 being capable of
promoting p75NTR-dependent re-entry into the cell cycle
in postmitotic cells, similar to that observed in the chick
retina. Nevertheless, an alternative explanation based on
the pro-apoptotic effects of NRIF1, independent of its
role in cell cycle regulation, cannot be ruled out.
Another link between cell death and p75NTR-
dependent regulation of the mitotic cycle is NRAGE, a
molecule capable of preventing cell cycle progression.
Interestingly, this molecule has been directly associated
with p75NTR-dependent apoptosis in the MAH
sympathoadrenal cell line, which lacks p75NTR and TrkA
receptors. These cells can be induced to die in the
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presence of NGF only when NRAGE and p75NTR are
co-expressed (Salehi et al., 2000). The interaction of
NGF with p75NTR in PC12 cells has been shown to
trigger the translocation of NRAGE from the cytoplasm
to the cell membrane (Salehi et al., 2000). Therefore, it
is conceivable that the diminution of the cytoplasmic
pool of NRAGE induced by the interaction of NGF with
p75NTR might favour cell cycle progression, and this
might account for cell death in cells already committed
to withdraw from the mitotic cycle.
Conclusion
All the findings described above highlight the
important role that the neurotrophins have in the
regulation of the cell cycle, a particular aspect of the
neurotrophin physiology that has not been sufficiently
acknowledged in the past. The role of neurotrophins in
cell cycle regulation has critical consequences for our
understanding of physiological processes such as
precursor cell expansion, tissue homeostasis, apoptosis,
and differentiation of cells that, like neurons, are
characterized by their post-mitotic status. In addition, a
role of neurotrophins in regulating the cell cycle in
pathogical situations like cancer and degenerative
diseases can also be envisaged. Therefore, it is
foreseeable that in the near future, stronger efforts will
be made to deepen our understanding of the molecular
events that underlie cell cycle regulation by
neurotrophins. This will also help us to determine to
what extent this aspect of neurotrophin physiology
influences normal and pathological cellular functions.
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